There’s a strange new phenomenon unfolding in pubs, bars, and social gatherings across the West: people are drinking less, not because they’ve become more health-conscious, but because of a side effect of the latest weight-loss miracle drugs. This isn’t just a quirky anecdote—it’s a seismic shift in how we relate to pleasure, addiction, and the very idea of moderation. Let me unpack why this matters, and what it could mean for our collective psyche.
When I first heard about this trend, I assumed it was another case of people prioritizing aesthetics over joy. But the stories from users like Lisa Rees and Warren Thomas reveal something deeper. These aren’t people voluntarily cutting out alcohol; they’re experiencing a physiological aversion to it. Lisa, a 46-year-old from Wales, used to guzzle two bottles of wine on a night out. Now, after two glasses, she feels physically incapable of consuming another drop. Warren, 45, says his tolerance for alcohol has vanished entirely—two beers now make him light-headed. This isn’t willpower; it’s a biological rewiring of the brain’s reward system.
What makes this particularly fascinating is the science behind it. These drugs, like Wegovy and Ozempic, contain semaglutide, a hormone that mimics GLP-1. It’s designed to suppress appetite, but its effects on the brain’s reward pathways are a happy accident—or perhaps an evolutionary quirk. Researchers like Dr. Christian Hendershot argue that these medications reduce cravings for not just food, but also substances like alcohol and nicotine. This raises a deeper question: If we can engineer drugs that dampen the desire for addictive behaviors, why do we still treat addiction as a moral failing rather than a biological one?
Here’s where it gets messy. For some, like Lisa, this is a liberation. She’s cut her wine consumption in half, and while she still enjoys socializing, she no longer feels compelled to drink excessively. But for others, like Faye Goodwin, a 20-year-old student, the trade-off is stark. She’s been on Mounjaro since 18, and now her ability to participate in university social life is compromised. When she drinks, she gets nauseous. She’s had to delay injections to attend parties, or skip them entirely. This isn’t just a personal inconvenience—it’s a social fracture. What does it mean to be part of a culture that revolves around alcohol when your body actively resists it?
Let’s talk about the broader implications. If these drugs are being prescribed off-label for alcohol use disorder, as some U.S. clinics are already doing, we’re entering uncharted territory. The FDA hasn’t approved them for this purpose, and there are unanswered questions about safety and accessibility. But here’s what’s truly radical: This could signal a shift in how we view addiction. If a drug can reduce cravings without requiring abstinence, therapy, or support groups, what does that say about the traditional models of recovery? It’s a challenge to the stigma that surrounds addiction, but it also risks reducing complex human struggles to a biochemical fix.
And then there’s the elephant in the room: affordability. These drugs are expensive, and their use for non-weight-related purposes could create a two-tiered system. Those who can afford them might enjoy a life free of alcohol’s grip, while others are left to grapple with the same old battles. It’s a chilling thought, but one that underscores the socioeconomic dimensions of health care.
What’s even more intriguing is the possibility that these drugs might one day be used for other addictions. Researchers are already exploring their potential for smoking and opioid addiction. If that becomes reality, we might be looking at a future where addiction is treated not through willpower or moral judgment, but through pharmacological intervention. But I can’t help wondering: Will this lead to a more compassionate society, or will it simply deepen the divide between those who can access these treatments and those who can’t?
In the end, this isn’t just about weight loss or alcohol consumption. It’s about how we define control, pleasure, and autonomy. Lisa, Warren, and Faye are living proof that our relationship with substances is far more nuanced than we often admit. Whether this trend is a breakthrough or a Pandora’s box remains to be seen. But one thing is certain: The world of health and addiction is changing, and it’s happening faster than most of us are prepared to understand.
